相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4
Zhili Cao et al.
ONCOLOGY RESEARCH (2018)
MiR-539 inhibits proliferation and migration of triple-negative breast cancer cells by down-regulating LAMA4 expression
Zhi-Xue Yang et al.
CANCER CELL INTERNATIONAL (2018)
DLX1, a binding protein of beta-catenin, promoted the growth and migration of prostate cancer cells
Ming Liang et al.
EXPERIMENTAL CELL RESEARCH (2018)
miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer
Jilong Guo et al.
SCIENTIFIC REPORTS (2018)
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
D. W. Chan et al.
ONCOGENE (2017)
miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion
Yanping Liu et al.
ONCOLOGY REPORTS (2017)
Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin
Liping Chen et al.
PHARMACOLOGICAL RESEARCH (2017)
Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression
Kenneth C. Valkenburg et al.
ONCOTARGET (2017)
miR-539 inhibits human colorectal cancer progression by targeting RUNX2
Dacheng Wen et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score
Leander Van Neste et al.
EUROPEAN UROLOGY (2016)
miR-539 inhibits prostate cancer progression by directly targeting SPAG5
Hongtuan Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
A network-biology perspective of microRNA function and dysfunction in cancer
Cameron P. Bracken et al.
NATURE REVIEWS GENETICS (2016)
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
Saeid Alinezhad et al.
PLOS ONE (2016)
SDHB deficiency promotes TGFβ-mediated invasion and metastasis of colorectal cancer through transcriptional repression complex SNAIL1-SMAD3/4
Haiyu Wang et al.
TRANSLATIONAL ONCOLOGY (2016)
MicroRNA-449a enhances radiosensitivity by downregulation of c-Myc in prostate cancer cells
Aihong Mao et al.
SCIENTIFIC REPORTS (2016)
Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling
Hadrien Demagny et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1
Lixue Gu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma
Haixia Cheng et al.
CANCER BIOLOGY & THERAPY (2015)
Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis
Mohammad Imran Khan et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
MicroRNA-590 is an EMT-suppressive microRNA involved in the TGFβ signaling pathway
Tianming Liu et al.
MOLECULAR MEDICINE REPORTS (2015)
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer
Hao Fu et al.
TUMOR BIOLOGY (2015)
PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis
Hong Pu et al.
CARCINOGENESIS (2014)
Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs
Samy Lamouille et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer
Bi-Lan Li et al.
MEDICAL ONCOLOGY (2013)
miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
Yosuke Harazono et al.
PLOS ONE (2013)
miR-200b Inhibits Prostate Cancer EMT, Growth and Metastasis
LaTanya V. Williams et al.
PLOS ONE (2013)
Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration
Qiang Shao et al.
CANCER LETTERS (2012)
MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma
Shujing Liu et al.
JOURNAL OF PATHOLOGY (2012)
Critical and Reciprocal Regulation of KLF4 and SLUG in Transforming Growth Factor β-Initiated Prostate Cancer Epithelial-Mesenchymal Transition
Yen-Nien Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
miRNA-29b Suppresses Prostate Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition Signaling
Peng Ru et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Annelid Distal-less/Dlx duplications reveal varied post-duplication fates
Carmel McDougall et al.
BMC EVOLUTIONARY BIOLOGY (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis
Berna Uygur et al.
MOLECULAR CANCER (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
MicroRNAs Associated with Metastatic Prostate Cancer
Akira Watahiki et al.
PLOS ONE (2011)
Serum miRNA-21: Elevated Levels in Patients With Metastatic Hormone-Refractory Prostate Cancer and Potential Predictive Factor for the Efficacy of Docetaxel-Based Chemotherapy
Hai-Liang Zhang et al.
PROSTATE (2011)
Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression
Kai-jie Wu et al.
ACTA PHARMACOLOGICA SINICA (2009)
Vimentin affects the mobility and invasiveness of prostate cancer cells
Yan Zhao et al.
CELL BIOCHEMISTRY AND FUNCTION (2008)
MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA
William Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer
Alan A. Aitchison et al.
PROSTATE (2008)
Homeoprotein DLX-1 interacts with Smad4 and blocks a signaling pathway from activin A in hematopoietic cells
S Chiba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
分享论文
